Deal Alchemist case study
Episode 6

Rentokil Terminix Acquisition: How a $6.7B Deal Became a Branch Test

Rentokil paid about $6.7 billion for Terminix to build route density in U.S. pest control. Cost savings came quickly, but branch integration slowed North American growth, and by 2025 only about 15% of Terminix branches were fully integrated.
Published Jul 25, 2026
Updated Oct 11, 2026
Rentokil & Terminix $6.7B
Acquirer
Rentokil Initial
Target
Terminix
Deal value
$6.7B
Announced
December 14, 2021
Closed
October 12, 2022
On this page
Share the case
Key takeaways

The deal model creates the promise; the branch decides whether it becomes EBITDA.

  • The price: $55 a share, about $6.7 billion of equity and a 47% premium, paid about 80% in Rentokil stock.
  • The thesis: route density. Pilot areas merged 40 branches into 23, and margins in those areas rose about 5 points.
  • The savings: $162 million gross and $105 million net cost synergies delivered by June 2024.
  • The bottleneck: about 15% of the Terminix branch network was fully integrated by March 2025, and one-time costs grew from about $150 million to about $350 million.
  • The reset: a 2025 pause, 100 satellite branches and a new CEO. North America grew 3.7% organically in H1 2026.
  • The lesson: underwrite integration at the branch, route and technician level, not just at corporate.

What Rentokil bought, and what it paid

The Rentokil Terminix acquisition was announced in December 2021. Rentokil Initial agreed to buy Terminix, the U.S. pest control and termite company, for $55 a share, about $6.7 billion of equity, a 47% premium to Terminix’s last closing price.

The deal was paid about 80% in Rentokil stock and 20% in cash. It closed on October 12, 2022, when Rentokil’s shares began trading on the New York Stock Exchange.

Deal termFigure
AnnouncedDecember 14, 2021 (December 13 in New York)
ClosedOctober 12, 2022 (about 10 months)
Price$55.00 per Terminix share; about $6.7 billion of equity
Premium47% to the prior close; 32.5% to the 90-day average
ConsiderationAbout $1.34 billion in cash plus about 646 million new Rentokil shares (as ADSs)
Terminix 2020 results$1.96 billion revenue; $345 million adjusted EBITDA
Implied multipleAbout 19x 2020 adjusted EBITDA, on equity value (our calculation)
Synergy target at signingAt least $150 million of annual net cost savings by year three, for about $150 million of one-time costs
Combined company at closeAbout 4.9 million customers and 57,700 employees

Rentokil was already a frequent buyer of smaller pest control companies, and Terminix was the biggest step yet in that pest control roll-up strategy. CEO Andy Ransom said it would create “the global leader in commercial, residential and termite pest control,” and North America grew to about 60% of group revenue by 2024.

Why route density drove the Rentokil Terminix acquisition

Pest control is a route business. A technician drives from stop to stop, so more customers on the same streets means fewer miles, more visits per day and fewer branches to run. Two networks covering the same cities should be cheaper to run as one.

On paper, the Rentokil Terminix acquisition was compelling. Rentokil said the combined company would have produced $5.7 billion of revenue, $1.2 billion of EBITDA and $608 million of free cash flow in 2020, and it expected mid-teens earnings accretion in the first full year. It also committed to bring leverage back to 2.0x to 2.5x net debt to EBITDA.

The early pilots proved the point. By mid-2023, Rentokil had exited 64 branch locations and merged 40 branches into 23 in two pilot areas, with margins in those areas up about 5 percentage points.

But the same report showed the risk. Colleague retention at Terminix was 67.7%, against 82.0% for the group. In a route business the technician is the service, so every departure hits the customer.

The synergy scoreboard

The cost case moved fast. Rentokil raised its target from $150 million to at least $200 million of annual net cost synergies by the end of 2025. By June 2024 it had delivered $162 million gross and $105 million net.

Bullet chart of Rentokil's Terminix cost synergies: $105 million net and $162 million gross delivered by June 2024, against an original target of $150 million set in December 2021 and a raised target of $200 million by the end of 2025. From March 2025 Rentokil stopped reporting net synergies and set a new goal of about $100 million of cost reduction versus 2024.
Figure 1. Gross savings beat the original target, but net synergies at the last reported count, in June 2024, were about half the raised goal. Source: Rentokil Initial releases, 2021 to 2025.

For the Rentokil Terminix acquisition, most of those savings came from route density and overhead: fewer properties, shared back-office systems and merged branches. The gap between gross and net is the cost of reinvestment, mostly marketing and field spending to protect growth. The one-time bill grew too: about $150 million at signing became about $350 million by 2025.

Cost synergies showed up on schedule. The branch integration that was meant to lock them in did not.

Tracking gross, net and reinvested savings separately is what synergy tracking is for. Forward Air’s Omni deal shows how a hit synergy target can still hide a weakening business.

Where the Rentokil Terminix acquisition slowed: the branch

The hard part began when integration moved from the back office into live branches. Each branch had to switch software, reroute technicians, change pay plans and keep selling. The first nine Terminix branches completed integration in June 2024.

In September 2024, Rentokil warned that North American trading in July and August was weaker than planned, with “some modest disruption to organic growth from branch integration.” The shares fell more than 18% in a day, three months after Nelson Peltz’s Trian had taken a stake.

By March 2025, only around 15% of the Terminix branch network was fully integrated. Rentokil said executing the integration had “clearly impacted” North America, and it stopped reporting net synergies.

Waffle chart of 100 squares with 15 filled, showing that about 15% of the Terminix branch network was fully integrated by March 2025, with milestones: deal closes October 2022; 64 locations exited and pilots merge 40 branches into 23 in H1 2023; first 9 Terminix branches complete integration in June 2024; integration paused for review in early 2025; commercial migrations restart in Q4 2025.
Figure 2. Two and a half years after closing, about 15% of the Terminix branch network was fully integrated. Source: Rentokil Initial results, 2023 to 2025.

This is where service roll-ups break. Branch systems migration, technician routing and pay-plan and retention design all land on the same people who answer the phone and win new customers. Walgreens and VillageMD is a reminder of how costly it is to scale a network before the local model is proven.

The reset: slower sequence, new leadership

Rentokil paused the integration at the start of 2025 and changed the order. It opened 100 small satellite branches by mid-2025, shifted marketing toward organic leads and restarted with the easiest cases, commercial branches already on its PestPac software, in late 2025.

The network is being rebuilt around local presence. Rentokil plans about 800 branches by the end of 2026, including about 220 small local ones, and will keep about 30 brands that cover more than 90% of revenue. For a pest control roll-up, that is a deliberate step back from one brand on one platform.

Results improved slowly. North American organic growth was 1.1% in the first half of 2025 and 2.3% for the full year. The company also raised its termite claims provision by $201 million in 2025, a liability that sits apart from any route-density savings.

In January 2026 Rentokil named Mike Duffy, former CEO of OnTrac and FleetPride, as chief executive, based in North America. In the first half of 2026, North America grew 3.7% organically with a 17.9% margin. Rentokil also retired its 20% North American margin target for 2027 to put volume growth first.

Nearly four years after the Rentokil Terminix acquisition closed, the balance sheet is back on plan: net debt was 2.4x adjusted EBITDA in June 2026, inside the 2.0x to 2.5x range set in 2021. The new CEO still said there was “more to do” on North American organic growth.

Heatmap scorecard of Rentokil North America by first half: H1 2023, back office and pilot branches, 4.1% organic growth and 18.5% adjusted margin; H1 2024, first branch migrations, 1.3% and 18.6%; H1 2025, integration paused and reviewed, 1.1% and 16.9%; H1 2026, commercial migrations resume, 3.7% and 17.9%.
Figure 3. Growth fell as branch migrations began and recovered after the reset; margin dipped in 2025 and is rebuilding. Source: Rentokil Initial interim results, 2023 to 2026.

The verdict so far: the Rentokil Terminix acquisition delivered scale and early savings, but the field integration took longer and cost more than planned. Unlike Uber Freight’s Transplace deal, where Uber kept Transplace’s leaders and connected the networks gradually, Rentokil had to rebuild the operating model branch by branch.

A branch-level checklist for service roll-ups

The Rentokil Terminix acquisition is a public-market case, but private equity buy-and-builds in HVAC, plumbing, landscaping and pest control face the same route density test at a smaller scale. Before the next add-on, check these at the branch, not just at corporate.

The core lesson: the deal model creates the promise; the branch decides whether it becomes EBITDA.

Sponsors who run several roll-ups need these steps to repeat across deals, which is the job of post-merger integration backed by an end-to-end M&A capability.

Sources

  1. Rentokil Initial, Acquisition of Terminix Global Holdings for stock and cash, December 13, 2021
  2. Rentokil Initial, Acquisition of Terminix completion, October 12, 2022
  3. Rentokil Initial, 2023 interim results, July 27, 2023
  4. Rentokil Initial, 2024 interim results, July 25, 2024
  5. Morningstar, Rentokil shares plummet on profit warning, September 11, 2024
  6. Rentokil Initial, 2024 preliminary results, March 6, 2025
  7. Rentokil Initial, 2025 half-year results, July 31, 2025
  8. Rentokil Initial, Rentokil Initial appoints Mike Duffy as Chief Executive, January 13, 2026
  9. Rentokil Initial, 2025 preliminary results, March 5, 2026
  10. Rentokil Initial, 2026 interim results, July 30, 2026

This analysis uses public information only. Xpertegic Partners did not advise on this transaction and has no non-public information about it. Figures are rounded, and estimates are labeled as such.

Dieunor Michel, CFA · Managing Partner, Xpertegic Partners

Dieunor leads Xpertegic's business operations and publishes the Deal Alchemist case study series and newsletter. Follow him on LinkedIn, where he posts new content every weekday at 9 AM ET.

Listen to every Deal Alchemist case study

Subscribe on Apple Podcasts or Spotify to hear the episode behind this case study and every deal in the series.

Other cases

Ready to Talk?

Let’s achieve extraordinary outcomes together.